2-((11H-dibenzo[b,e]azepin-6-yl)methyl)isoindoline-1,3-dione

Catalog No. :
ACBKTY705
CAS No. :
74860-00-7
Molecular Formula :
C23H16N2O2
Molecular Weight :
352.39

IUPAC Name:2-((11H-dibenzo[b,e]azepin-6-yl)methyl)isoindoline-1,3-dione

2-((11H-dibenzo[b,e]azepin-6-yl)methyl)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((11H-dibenzo[b,e]azepin-6-yl)methyl)isoindoline-1,3-dione
IUPAC Name2-((11H-dibenzo[b,e]azepin-6-yl)methyl)isoindoline-1,3-dione
Molecular FormulaC23H16N2O2
Molecular Weight352.39
SMILESO=C1C2=CC=CC=C2C(=O)N1CC1=NC2=CC=CC=C2CC2=CC=CC=C12
InChI KeyQAVFEJRLIYLUBJ-UHFFFAOYSA-N
Synonym6-(Phthalimidomethyl)morphanthridine;2-(11H-Dibenz[b,e]azepin-6-ylMethyl)-1H-isoindole-1,3(2H)-dione;2-(11H-benzo[c][1]benzazepin-6-ylmethyl)isoindole-1,3-dione;2-((11H-Dibenzo[b,e]azepin-6-yl)methyl)isoindoline-1,3-dione;1H-Isoindole-1,3(2H)-dione, 2-(11H-dibenz[b,e]azepin-6-ylmethyl)-;Epinastine Impurity 12;2-(11H-dibenzo[b,e]azepin-6-ylmethyl)-1H-isoindole-1,3(2H)-dione;Epinastine Impurity 8/2-((11H-Dibenzo[b,e]azepin-6-yl)methyl)isoindoline-1,3-dione
CAS No.74860-00-7

Synthetic Route by SureRoute

1. ACBKTY705 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBKTY705 route product structure diagram
    ACBKTY70574860-00-7
Inquiry

2. ACBKTY705 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACBKTY705 route product structure diagram
    ACBKTY70574860-00-7
Inquiry

Comments (0)